169 related articles for article (PubMed ID: 32910461)
1. The dynamics of immune response in COVID-19 patients with different illness severity.
Zhang B; Yue D; Wang Y; Wang F; Wu S; Hou H
J Med Virol; 2021 Feb; 93(2):1070-1077. PubMed ID: 32910461
[TBL] [Abstract][Full Text] [Related]
2. Immune cell profiling and antibody responses in patients with COVID-19.
Rezaei M; Mahmoudi S; Mortaz E; Marjani M
BMC Infect Dis; 2021 Jul; 21(1):646. PubMed ID: 34225645
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
[TBL] [Abstract][Full Text] [Related]
5. Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Qu J; Wu C; Li X; Zhang G; Jiang Z; Li X; Zhu Q; Liu L
Clin Infect Dis; 2020 Nov; 71(16):2255-2258. PubMed ID: 32337590
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge.
Shen Y; Ba Y; Hu Y; Wang L; Li W
Inflamm Res; 2021 Feb; 70(2):241-247. PubMed ID: 33385239
[TBL] [Abstract][Full Text] [Related]
7. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.
Zhang P; Du W; Yang T; Zhao L; Xiong R; Li Y; Geng Y; Lu W; Zhou J
Int J Immunopathol Pharmacol; 2021; 35():20587384211048567. PubMed ID: 34619994
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus.
Liu D; Lan L; Luo D; Zhao B; Wei G; He Y; Zhang R; Liu Y
Diabetes Res Clin Pract; 2020 Sep; 167():108341. PubMed ID: 32707212
[TBL] [Abstract][Full Text] [Related]
10. Sex-based clinical and immunological differences in COVID-19.
Huang B; Cai Y; Li N; Li K; Wang Z; Li L; Wu L; Zhu M; Li J; Wang Z; Wu M; Li W; Wu W; Zhang L; Xia X; Wang S; Chen H; Wang Q
BMC Infect Dis; 2021 Jul; 21(1):647. PubMed ID: 34225644
[TBL] [Abstract][Full Text] [Related]
11. The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes.
Tang G; Huang M; Luo Y; Liu W; Lin Q; Mao L; Wu S; Xiong Z; Hou H; Sun Z; Wang F
Front Immunol; 2021; 12():697622. PubMed ID: 34777333
[TBL] [Abstract][Full Text] [Related]
12. How immune breakthroughs could slow disease progression and improve prognosis in COVID-19 patients: a retrospective study.
Wang Y; Zhao B; Zhang X; Zhang X; Gao F; Yuan X; Ren X; Li M; Liu D
Front Immunol; 2023; 14():1246751. PubMed ID: 37936709
[TBL] [Abstract][Full Text] [Related]
13. The clinical course and its correlated immune status in COVID-19 pneumonia.
He R; Lu Z; Zhang L; Fan T; Xiong R; Shen X; Feng H; Meng H; Lin W; Jiang W; Geng Q
J Clin Virol; 2020 Jun; 127():104361. PubMed ID: 32344320
[TBL] [Abstract][Full Text] [Related]
14. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
[TBL] [Abstract][Full Text] [Related]
15. Value and Validity of Coronavirus Antibody Testing.
Mahajan A; Manchikanti L
Pain Physician; 2020 Aug; 23(4S):S381-S390. PubMed ID: 32942795
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
[TBL] [Abstract][Full Text] [Related]
17. Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study.
Qian F; Gao G; Song Y; Xu Y; Wang A; Wang S; Hao Y; Chen M; Ma X; Zhao T; Guo X; Chen Z; Zhang F
BMC Infect Dis; 2020 Dec; 20(1):910. PubMed ID: 33261583
[TBL] [Abstract][Full Text] [Related]
18. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
19. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
Ni M; Tian FB; Xiang DD; Yu B
J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
